Drug · DIN 02421348
MINT-RAMIPRIL
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since April 5, 2023; first marketed March 17, 2014.
- Drug Identification Number (DIN)
- 02421348
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Ramipril C09AA05
- Class
- Human
- Record last updated
- April 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RAMIPRIL | 15 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 6, 2014: NOC 15391Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named MINT-RAMIPRIL
- DIN 02421305 · Marketed
- DIN 02421313 · Marketed
- DIN 02421321 · Marketed
- DIN 02421291 · Approved